Tech Company Financing Transactions
GTC Biotherapeutics Funding Round
GTC Biotherapeutics closed a $7 million funding round on 6/16/2010. Backers included private investors.
Transaction Overview
Company Name
Announced On
6/16/2010
Transaction Type
Debt
Amount
$7,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
175 Crossing Blvd.
Framingham, MA 01702
USA
Framingham, MA 01702
USA
Phone
Website
Email Address
Not Recorded
Overview
GTC Biotherapeutics develops, produces, and commercializes therapeutic proteins through transgenic animal technology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Financial Officer
Marc Becker
President
Yann Echelard
VP - Product Management
Rick Finnegan
VP - Regulatory Affairs
Mary Murphy
Browse more venture capital transactions:
Prev: 6/16/2010: Predictive BioSciences venture capital transaction
Next: 6/16/2010: KXEN venture capital transaction
Share this article
About Our Venture Capital Transactions Database
Our team works diligently to report on every notable VC transaction. VC investment data records on this site are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs